
QMS Medical Q4 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 2
Fundraise
N/A
Order
Yes
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- →Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27.
- →Aim to double revenue from the services segment (camps and patient service programs) from around INR50 crores in FY26 to INR100 crores.
- →Overall revenue guidance for FY27 remains around INR216 crores.
- →Product segment expected to grow at 10-15% annually.
- →Services segment growth driven by new contracts, especially with GLP-1 drug patient engagement programs.
- →Plan to expand number of camps (32,380 conducted in FY26), though not necessarily doubling camp count next year.
- →Employee hiring targeted around 1,200 for patient service programs to support revenue growth.
- →EBITDA margin improvement expected with stabilized investments in people, technology, and infrastructure.
Margin guidance
Category 2- →QMS Medical Allied Services targets to increase service revenue from INR 50 crores in FY26 to around INR 100 crores by FY27, mainly driven by patient service programs and camps.
- →Revenue from camps is expected to grow from approx. INR 13 crores in FY26 to INR 18-20 crores in FY27.
- →The company aims to maintain EBITDA margins at around 18-19% in FY27, with service segment margins at approximately 25% EBITDA and product segment margins at 10-12% EBITDA.
- →Revenue growth guidance for FY27 remains INR 216 crores, in line with earlier guidance.
- →Profitability is expected to improve as investments in people, technology, and infrastructure (front-loaded in FY26) begin to yield returns.
- →Margins compressed in FY26 due to investments for new patient service programs; growth in FY27 expected to reflect a recovery.
- →EPS growth to follow overall revenue and margin growth, driven by scaling service revenues and contract-backed patient programs.
3 more insights locked — sign up free to unlock
Fundraise plans
Order book
Yes- →The company experienced order delays in Q3 and Q4 FY26, primarily on the product segment, due to supply chain and shipping disruptions.
- →Some March orders were pushed into April and May.
- →Management expects smoother order flow and positive growth in Q1 and Q2 FY27 compared to the previous year.
- →No specific quantitative order book or pending orders value was disclosed in the transcript.
- →Confidence expressed in improving the supply-side challenges moving forward.
Capex plans
Yes- →The company is making significant investments in its service segment, focusing on people, infrastructure, and technology to double service revenue in FY26-27.
- →Investments include hiring new employees (targeting 1,200 hires, with 800-850 already onboarded as of May) for patient service programs.
- →Capital is being allocated to software development and data compliance systems to meet DPDP Act requirements and enhance service capabilities.
- →These investments involve intangible assets such as people and custom software, which are expensed currently rather than capitalized.
- →Equipment for camp employees is a fixed cost (INR 20-25 lakh worth per employee) to support the expansive network covering 5,000 pin codes.
- →No explicit mention of large-scale traditional capex or strategic acquisitions; emphasis is on building scalable business infrastructure and service capabilities.
How does QMS Medical rank vs peers in Healthcare Equipment & Supplies?
Pro featureSee full Healthcare Equipment & Supplies sector rankings
How does QMS Medical rank in Healthcare Equipment & Supplies?
Compare QMS Medical against every Healthcare Equipment & Supplies company (Q4 FY26) on revenue, margins and earnings-call signals.